Pressotherapy Systems Market Segmentation:
Distribution Segment Analysis
The direct sales (B2B) segment is expected to hold the largest share of 52.7% by the end of 2035. The segment’s growth is highly attributed to increased procurement from hospitals, rehabilitation centers, and specialty clinics. In addition, the segment is also thriving, owing to long-lasting contracts with institutional purchasing power, government tenders, and healthcare service providers. For instance, the majority of hospitals in Europe supply pressotherapy devices through B2B collaboration, while Medicaid and Medicare reimbursements in the U.S. have deliberately incentivized bulk orders. Besides, notable organizations are leveraging direct sales to provide personalized maintenance and solutions, thus suitable for the segment’s upliftment.
End user Segment Analysis
The hospitals segment is projected to account for the second-largest share of 47.3% during the forecast timeline. According to an article published by NLM in August 2024, a survey was conducted on 86 hospitals in Australia, wherein it was disclosed that facility-based pressure ulcer rates varied from 7.8% to 9.3%, 6.3%, and 7.4%, over the past years. Besides, in the U.S., approximately 2.5 million patients receive standard medical treatment for pressure injuries in hospital facilities, leading to an expense of USD 9.1 billion to USD 11.6 billion. Therefore, hospitals are considered the most suitable hub for aiding patients with diseases, which denotes a huge opportunity for market growth.
Product Segment Analysis
The pneumatic compression devices segment is anticipated to garner the third-largest share of 43.8% during the projected duration. This device has been developed, owing to its capability to duplicate the principles and process of manual lymphatic drainage (MLD). In this regard, the October 2022 NLM article conducted a clinical trial on 40 patients affected with lower limb ISL Stage II. These patients were divided into three categories, ranging from A, B, and C, and Group A patients demonstrated a diminish in limb volume by 38.4%. This was followed by Group B displaying a 13.1% reduction and 11.8% for Group C, thus proliferating the overall segment.
Our in-depth analysis of the global market includes the following segments:
|
Segment |
Subsegments |
|
Distribution |
|
|
End user |
|
|
Product |
|
|
Application |
|
|
Technology |
|
|
Compression Type |
|
